Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune systems

Experimental Dermatology

Volumn 7, Issue 2-3, 1998, Pages 81-96

  Scholzen, T ^f   Armstrong, C A ^b   Bunnett, N W ^c   Luger, T A ^d   Olerud, J C ^e   Ansel, J E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Services Inc   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Calcitonin gene related peptide; Neuropeptides; Sensory nerves; Skin immune system; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; SOMATOSTATIN; SUBSTANCE P; TACHYKININ DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIGEN PRESENTATION; CYTOKINE PRODUCTION; FIBROBLAST; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; KERATINOCYTE; NEUROENDOCRINE SYSTEM; NEUROGENIC INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SENSORY NERVE; SKIN INFLAMMATION; SKIN NERVE;

EID: 0031895454     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1998.tb00307.x     Document Type: Review

References (198)

1. Malinovsky L. Sensory nerve formations in the skin and their classification. Microsc Res Tech 1996: 34: 283-301.
2. Sternini C. Organization of the peripheral nervous system: Autonomie and sensory ganglia. J Invest Dermatol Symp Proc 1997: 2: 1-7.
3. Hilliges M, , Wang L, , Johansson O. Ultrastructural evidence for nerve fibres within all vital layers of the human epidermis. J Invest Dermatol 1995: 104: 134-137.
4. Kennedy W R, , Wendelschafer-Crabb G, , Brelje T C. Innervation and vasculature of human sweat glands: an immunohistochemistry-laser scanning confocal fluorescence microscopy study. J Neurosci 1994: 14: 6825-6833.
5. Fantini F, , Johansson O. Neurochemical markers in human cutaneous Merkel cells. An immunohistochemical investigation. Exp Dermatol 1995: 4: 365-371.
6. Reilly D M, , Ferdinande D, , Johnston C, , Shaw C, , Buchanan K D, , Green M R. The human epidermal nerve fibre network: characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variations. Br J Dermatol 1997: 137: 163-170.
7. Lawson S N. Peptides and cutaneous polymodal nociceptor neurones. Prog Brain Res 1996: 113: 369-385.
8. Holzer P. Capsaicin: cellular targets, , mechanism of action, , and selectivity for thin sensory neurons. Pharmacol Rev 1991: 43: 144.
9. Caterina M J, , Schumacher M A, , Tominaga M et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997: 389: 816-824.
10. Szallasi A. The vanilloid (capsaicin) receptor: receptor types and species differences. Gen Pharmacol 1994:25:223.
11. Bevan S, , Docherty R J. The ionic basis of capsaicinevoked responses. In: Geppetti P, , Holzer P, , eds.Neurogenic inflammation. Boca Raton: CRC Press Inc. 1996: 53-67.
12. Bevan S, , Forbes C A. Winter J. Protons and capsaicin activate the same ion channels in rat isolated dorsal root ganglion neurons. J Physiol (Lond) 1993: 459: 401.
13. Johansson O. A detailed account of NPY-immunoreactive nerves and cells of the human skin. Comparison with VIP-, , substance P- and PHI-containing structures. Acta Physiol Scand 1986: 128: 147-153.
14. Johansson O. Evidence for PHI-immunoreactive nerve fibres in the human skin: coexistence with VIP? Medical Biology 1986: 64: 67-73.
15. Tainio H, , Vaalasti A, , Rechardt L. The distribution of substance P-, , CGRP-, , galanin- and ANP-like immunoreactive nerves in human sweat glands. Histochem J 1987: 19: 375-380.
16. Luger T A, , Scholzen T, , Grabbe S. The role of a-melanocyte-stimulating hormone in cutaneous biology. J Invest Dermatol Symp Proc 1997: 2: 87-93.
17. Schulze E, , Witt M, , Fink T, , Hofer A, , Funk R H. Immunohistochemical detection of human skin nerve fibers. Acta Histochemica 1997: 99: 301-309.
18. Burke J F, , Bright K E, , Kellett E, , Benjamin P R, , Saunders S E. Alternative mRNA splicing in the nervous system. Prog Brain Res 1992: 92: 115-125.
19. Marchand J E, , Zaccheo T S, , Connelly C S, , Kream R M. Selective in situ hybridization histochemical analyses of alternatively spliced mRNAs encoding beta- and gammapreprotachykinins in rat central nervous system. Brain Res 1993: 17: 83-94.
20. Khan I, , Collins S M. Fourth isoform of preprotachykinin messenger RNA encoding for substance P in the rat intestine. Biochem Biophys Res Commun 1994: 202: 796-802.
21. Dray A. Afferent responses of sensory neurons. In: Geppetti P, , Holzer P, , eds. Neurogenic inflammation. Boca Raton: CRC Press, , Inc. 1996: 69-79.
22. Freidin M, , Kessler J A. Cytokine regulation of substance P expression in sympathetic neurons. Proc Natl Acad Sci USA 1991: 88: 3200-3203.
23. Vedder H, , Affolter H U, , Otten U. Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurons during early postnatal development. Neuropeptides 1993: 24: 351-357.
24. Bost K L, , Breeding S A, , Pascual D W. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. Reg Immunol 1992:4:105-112.
25. Fong T M. Molecular biology of tachykinins. In: Geppetti P, , Holzer P, , eds. Neurogenic inflammation. Boca Raton: CRC Press, , Inc. 1996: 3-14.
26. Regoli D, , Boudon A, , Fauchere J L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994: 46: 551-599.
27. Carlton S M, , Zhou S, , Coggeshall R E. Localization and activation of substance P receptors in unmyelinated axons of rat glabrous skin. Brain Res 1996: 734: 103-108.
28. Ho W Z, , Lai J P, , Zhu X H, , Uvaydova M, , Douglas S D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997: 159: 5654-5660.
29. Ansei J C, , Brown J R, , Payan D G, , Brown M A. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993: 150: 4478485.
30. Parent! A, , Amerini S, , Ledda F, , Maggi C A, , Ziehe M. The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn-Schmiedebergs Arch Pharmacol 1996: 353: 475-481.
31. Brown J R, , Perry P, , Hefeneider S, , Ansei J C. Neuropeptide modulation of keratinocyte cytokine production. In: Oppenheim, , Powanda, , Kluger, , Dinarello, , eds. Molecular and cellular biology of cytokines. Wiley-Liss, , Inc. 1990: 451-456.
32. Bunnett N W, , Song I S, , Grady E F et al. Localization of neurokinin receptors on transfected cell lines, , keratinocytes, , and dermal microvascular endothelial cells. J Invest Dermatol 1996: 106: 814 [Abstract].
33. Staniek V, , Misery L, , Peguet-Navarro J et al. Binding and in vilro modulation of human epidermal Langerhans cell functions by substance P. Arch Dermatol Res 1997: 289: 285-291.
34. Ohkubo H, , Nakanishi S. Molecular characterization of the three tachykinin receptors. Ann N Y Acad Sci 1991: 632: 53-62.
35. Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci 1991: 14: 123-136.
36. Regoli D, , Nguyen K, , Calo G. Neurokinin receptors. Comparison of data from classical pharmacology, , binding, , and molecular biology. Ann N Y Acad Sci 1997: 812: 144-146.
37. Regoli D, , Drapeau G, , Dion S, , D'Orléans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci 1987:40: 109-117.
38. Bohm S K, , Khitin L M, , Smeekens S P, , Grady E F, , Payan D G, , Bunnett N W. Identification of potential tyrosinecontaining endocytic motifs in the carboxyl-tail and seventh transmembrane domain of the neurokinin 1 receptor. J Biol Chem 1997: 272: 2363-2372.
39. Koizumi H, , Yasui C, , Fukaya T, , Ueda T, , Ohkawara A. Substance P induces inositol 1,4,5-trisphosphate and intracellular free calcium increase in cultured normal human epidermal keratinocytes. Exp Dermatol 1994: 3: 40-44.
40. Mitsuhashi M, , Ohashi Y, , Shichijo S et al. Multiple intracellular signaling pathways of the neuropeptide substance P receptor. J Neurosci Res 1992: 32: 437143.
41. Luo W, , Sharif T R, , Sharif M. Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res 1996: 56: 4983-4991.
42. Columbo M, , Horowitz E M, , Kagey-Sobotka A, , Lichtenstein L M. Substance P activates the release of hista-mine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. Clin Immunol Immunopathol 1996: 81: 68-73.
43. Lieb K, , Fiebich B L, , Berger M, , Bauer J, , Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-KB and KB-dependent gene expression in human astrocytoma cells. J Immunol 1997: 159: 4952-4958.
44. Christian C, , Gilbert M, , Payan D G. Stimulation of transcriptional regulatory activity by substance P. Neuroimmunomodulation 1994: 1: 159-164.
45. Garland A M, , Grady E F, , Payan D G, , Vigna S R, , Bunnett N W. Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells. Biochem J 1994: 303: 177-186.
46. Garland A M, , Grady E F, , Lovett M et al. Mechanisms of desensitization and resensitization of G protein-coupled neurokininl and neurokinin2 receptors. Mol Pharmacol 1996: 49: 438-446.
47. Eedy D J. Neuropeptides in skin. Br J Dermatol 1993: 128: 597-605.
48. Naukkarinen A, , Jarvikallio A, , Lakkakorpi J, , Harvima I T, , Harvima R J, , Horsmanheimo M. Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin. J Pathol 1996: 180: 200-205.
49. Bowden J J, , Baluk P, , Lefevre P M, , Vigna S R, , McDonald D M. Substance P (NK1) receptor immunoreactivity on endothelial cells of the rat trachéal mucosa. Am J Physiol 1996: 270: L404-414.
50. Ziehe M, , Morbidelli L, , Parenti A, , Amerini S, , Granger H J, , Maggi C A. Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells. Life Sci 1993: 53: PL229-234.
51. Johansson O, , Virtanen M, , Hilliges M. Histaminergic nerves demonstrated in the skin. A new direct mode of neurogenic inflammation? Exp Dermatol 1995: 4: 93-96.
52. Figini M, , Emanueli C, , Grady E F et al. Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol 1997: 272: G785-793.
53. Bozic C R, , Lu B, , Hopken U E, , Gerard C, , Gerard N P. Neurogenic amplification of immune complex inflammation. Science 1996: 273: 1722-1725.
54. Viac J, , Gueniche A, , Doutremepuich J D, , Reichert U, , Claudy A, , Schmitt D. Substance P and keratinocyte activation markers: an in vitro approach. Arch Dermatol Res 1996: 288: 85-90.
55. Quinlan K L, , Olerud J, , Armstrong C A, , Caughman S W, , Ansei J C. Neuropeptides upregulate expression of adhesion molecules on human keratinocytes and dermal microvascular endothelial cells. J Invest Dermatol 1997: 108: 551 [Abstract].
56. Smith C H, , Barker J N, , Morris R W, , MacDonald D M, , Lee T H. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 1993: 151: 3274-3282.
57. Sung K J, , Kaynard A H, , Brown J, , Armstrong C A, , Ansel J C. Neurokinin modulation of normal human keratinocyte cytokine production. J Invest Dermatol 1993: 101: 407 [Abstract].
58. Kramp J, , Brown J, , Cook P et al. Neuropeptide induction of human microvascular endothelial cell interleukin 8. J Invest Dermatol 1995: 104: 586 [Abstract].
59. Paus R, , Heinzelmann T, , Robicsek S, , Czarnetzki B M, , Maurer M. Substance P stimulates murine epidermal . keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res 1995: 287: 500-502.
60. McGovern U B, , Jones K T, , Sharpe G R. Intracellular calcium as a second messenger following growth stimula-tion of human keratinocytes. Br J Dermatol 1995: 132: 892-896.
61. Nilsson J, , von Euler A M, , Dalsgaard C J. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985: 315: 61-63.
62. Ziehe M, , Morbidelli L, , Pacini M, , Dolara P, , Maggi C A. NKl-receptors mediate the proliferative response of human fibroblasts to tachykinins. Br J Pharmacol 1990: 100: 11-14.
63. Wiedermann C J, , Auer B, , Sitte B, , Reinisch N, , Schratzberger P, , Kahler C M. Induction of endothelial cell differentiation into capillary-like structures by substance P. Eur J Pharmacol 1996: 298: 335-338.
64. Amara S G, , Evans R M, , Rosenfeld M G. Calcitonin/calcitonin gene-related peptide transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites. Mol Cell Biol 1984: 4: 2151-2160.
65. Emeson R B. Posttranscriptional regulation of calcitonin gene-related peptide (CGRP) mRNA production. In: Geppetti P, , Holzer P, , eds. Neurogenic inflammation. Boca Raton: CRC Press, , Inc. 1996: 15-30.
66. Amara S G, , Arriza J L, , Leff S E, , Swanson L W, , Evans R M, , Rosenfeld M G. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calci. tonin gene-related peptide. Science 1985: 229: 1094-1097.
67. Sternini C. Enteric and viscerent afferent CGRP neurons. Targets of innervation and differential expression patterns. Ann N Y Acad Sci 1992: 657: 170
68. Kresse A, , Jacobowitz D M, , Skofitsch G. Distribution of calcitonin gene-related peptide in the central nervous system of the rat by immunocytochemistry and in situ hybridisation histochemistry. Ann N Y Acad Sci 1992: 657: 455-457.
69. Wallengren J, , Ekman R, , Sundler F. Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol 1987: 67: 185-192.
70. Gibbins I L, , Wattchow D, , Coventry B. Two immunohistochemically identified populations of calcitonin gene-related peptide (CGRP)-immunoreactive axons in human skin. Brain Res 1987: 414: 143-148.
71. Botchkarev V A, , Eichmuller S, , Peters E M et al. A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle-dependent changes in mast cell-nerve fiber contacts in murine skin. Arch Dermatol Res 1997: 289: 292-302.
72. Hara M, , Toyoda M, , Yaar M et al. Innervation of melanocytes in human skin. J Exp Med 1996: 184: 1385-1395.
73. Asahina A, , Hosoi J, , Grabbe S, , Granstein R D. Modulation of Langerhans cell function by epidermal nerves. J Allergy Clin Immunol 1995: 96: 1178-1182.
74. Hosoi J, , Murphy G F, , Egan C L et al. Regulation of Langerhans cell function by nerves containing calcitonin generelated peptide. Nature 1993: 363: 159-163.
75. Gillardon F, , Morano I, , Zimmermann M. Ultraviolet irradiation of the skin attenuates calcitonin gene-related peptide mRNA expression in rat dorsal root ganglion cells. Neurosci Lett 1991: 124: 144-147.
76. Dumont Y, , Fournier A, , St-Pierre S, , Quirion R. A potent and selective CGRP2 agonist, , [Cys(Et)2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays. Can J Physiol Pharmacol 1997: 75: 671-676.
77. Aiyar N, , Rand K, , Elshourbagy N A et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996: 271: 11325-11329.
78. Luebke A E, , Dahl G P, , Roos B A, , Dickerson I M. Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay. Proc Natl Acad Sci USA 1996: 93: 3455-3460.
79. Naghashpour M, , Rosenblatt M I, , Dickerson I M, , Dahl G P. Inhibitory effect of calcitonin gene-related peptide on myometrial contractility is diminished at parturition. Endocrinology 1997: 138: 4207-4214.
80. Laufer R, , Changeux J P. Calcitonin gene-related peptide and cyclic AMP stimulate phosphoinositide turnover in skeletal muscle cells. Interaction between two second messenger systems. J Biol Chem 1989: 264: 2683-2689.
81. Jansen-Olesen I, , Mortensen A, , Edvinsson L. Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia 1996: 16: 310-316.
82. Brain S D, , Tippins J R, , Morris H R, , Maclntyre I, , Williams T J. Potent vasodilator activity of calcitonin generelated peptide in human skin. J Invest Dermatol 1986: 87: 533-536.
83. Ottosson A, , Edvinsson L. Release of histamine from durai mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 1997: 17: 166-174.
84. Hong K W, , Yoo S E, , Yu S S, , Lee J Y, , Rhim B Y. Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles. Am J Physiol 1996: 270: H317-323.
85. Gonzalez C, , Barroso C, , Martin C, , Gulbenkian S, , Estrada C. Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries. J Cereb Blood Flow Metab 1997: 17: 977-984.
86. Bruch-Gerharz D, , Ruzicka T, , Kolb-Bachofen V. Nitric oxide in human skin: Current status and future prospects. J Invest Dermatol 1998: 110: 1-7.
87. Bull H A, , Hothersall J, , Chowdhury N, , Cohen J, , Dowd P M. Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells. J Invest Dermatol 1996: 106: 655-660.
88. Benrath J, , Eschenfelder C, , Zimmerman M, , Gillardon F. Calcitonin gene-related peptide, , substance P and nitric oxide are involved in cutaneous inflammation following ultraviolet irradiation. Eur J Pharmacol 1995: 293: 8796.
89. Holzer P, , Wächter C, , Heinemann A, , Jocic M, , Lippe I T, , Herbert M K. Diverse interactions of calcitonin gene related peptide and nitric oxide in the gastric and cutaneous microcirculation. Can J Physiol Pharmacol 1995: 73: 991-994.
90. Ozaka T, , Doi Y, , Kayashima K, , Fujimoto S. Weibel-Palade bodies as a storage site of calcitonin gene-related peptide and endothelin-1 in blood vessels of the rat carotid body. Anat Rec 1997: 247: 388-394.
91. Kawaguchi Y, , Okada T, , Konishi H, , Fujino M, , Asai J, , Ito M. Reduction of the DTH response is related to morphological changes of Langerhans cells in mice exposed to acute immobilization stress. Clin Exp Immunol 1997: 109: 397101.
92. Al'Abadie M S, , Senior H J, , Blechen S S, , Gawkrodger D J. Neuropeptides and general neuronal marker in psoriasis - an immunohistochemical study. Clin Exp Dermatol 1995: 20: 384-389.
93. Haegerstrand A, , Dalsgaard C J, , Jonzon B, , Larsson O, , Nilsson J. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 1990: 87: 3299-3303.
94. Ichinose M, , Sawada M. Enhancement of phagocytosis by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages. Peptides 1996: 17: 1405-1414.
95. Sung C P, , Arleth A J, , Aiyar N, , Bhatnagar P K, , Lysko P G, Feuerstein G. CGRP stimulates the adhesion of leukocytes to vascular endothelial cells. Peptides 1992: 13:429-434.
96. Buckley T L, , Brain S D, , Collins P D, , Williams T J. Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J Immunol 1991: 146: 3424-3430.
97. Niizeki H, , Alard P, , Streilein J W. CGRP is necessary for ultraviolet B-impaired induction of contact hypersensitivity. J Immunol 1997: 159: 5183-5186.
98. Montminy M, , Brindle P, , Arias J, , Ferreri K, , Armstrong R. Regulation of somatostatin gene transcription by cyclic adenosine monophosphate. Metabolism 1996: 45: 4-7.
99. Reisine T. Somatostatin. Cell Mol Neurobiol 1995: 15: 597-614.
100. Johansson O, , Hilliges M, , Wang L. Somatostatin-like immunoreactivity is found in dendritic guard cells of human sweat ducts. Peptides 1993: 14: 401-403.
101. Misery L, , Gaudillere A, , Claudy A, , Schmitt D. Expression of somatostatin on Laneerhans cells. Adv Exp Med Biol 1995:378: 109-110.
102. Gaudillere A, , Misery L, , Bernard C, , Souchier C, , Claudy A, , Schmitt D. Presence of somatostatin in normal human epidermis. Br J Dermatol 1997: 137: 376-380.
103. Pincelli C, , Fantini F, , Massimi P, , Girolomoni G, , Seidenari S, , Giannetti A. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990: 122: 745-750.
104. Bruns C, , Weckbecker G, , Raulf F, , Lubbert H, , Hoyer D. Characterization of somatostatin receptor subtypes. Ciba Found Symp 1995: 190: 89-101.
105. Hoyer D, , Bell G I, , Berelowitz M et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 1995: 16: 86-88.
106. Lopez F, , Esteve J P, , Buscail L et al. Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase. Metabolisml996: 45: 14-16.
107. Reichlin S. Somatostatin. N Ensl J Med 1983: 309: 1495-1501.
108. Liebow C, , Lee M T, , Schally A V. Antitumoral effects of somatostatin mediated by the stimulation of thyrosine phosphatase. Metabolism: 1990: 39: 163-166.
109. Buscail L, , Delesque N, , Esteve J P et al. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl . Acad Sci USA 1994: 91: 2315-2319.
110. Payan D G, , Hess C A, , Goetzl E J. Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol 1984: 84: 433138.
111. Goetzl E J, , Payan D G. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J Immunol 1984: 133: 3255-3259.
112. Church M K, , Okayama Y, , el-Lati S. Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation. Skin Pharmacol 1991:4(Suppl. 1): 15-24.
113. Scicchitano R, , Stanisz A M, , Payan D G, , Kiyono H, , McGhee J R, , Bienenstock J. Expression of substance P and somatostatin receptors on a T helper cell line. Adv Exp Med Biol 1987: 216A: 185-190.
114. Scicchitano R, , Dazin P, , Bienenstock J, , Payan D G, , Stanisz AM. Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes. Brain Behav Immun 1987: 1: 173-184.
115. Leszczynski D, , Josephs M D, , Fournier R S, , Foegh M L. Angiopeptin, , the octapeptide analogue of somatostatin, , decreases rat heart endothelial cell adhesiveness for mononuclear cells. Regul Pept 1993: 43: 131-140.
116. Johansson O. Morphological characterization of the somatostatin-immunoreactive dendritic skin cells in urticaria piamentosa patients by computerized image analysis. Scand J Immunol 1985: 21: 431-439.
117. Guilliou J J. Growth hormone, , somatostatin and psoriasis. Dermatologica 1990: 181: 81-82.
118. Dockray G J. Evolutionary relationships of the gut hormones. Fed Proc 1979: 38: 2295-2301.
119. Itoh H, , Obata K, , Yanaihara N, , Okamoto H. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, , PHM-27. Nature 1983: 304: 547-548.
120. Duckies S P. Innervation of the cerebral vasculature. Ann Biomed Eng 1983: 11: 599-605.
121. Hartschuh W, , Weihe E, , Yanaihara N, , Reinecke M. Immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in Merkel cells of various mammals: evidence for a neuromodulator function of the Merkel cell. J Invest Dermatol 1983: 81: 361-364.
122. Du K, , Nicole P, , Couvineau A, , Laburthe M. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production. Biochem Biophys Res Commun 1997: 230: 289-292.
123. Mulderry P K, , Dobson S P. Regulation of VIP and other neuropeptides by c-Jun in sensory neurons: implications for the neuropeptide response to axotomy. Eur J Neurosci 1996: 8: 2479-2491.
124. Heinz-Erian P, , Paul S, , Said S I. Receptors for vasoactive intestinal peptide on isolated human sweat glands. Peptides 1986: 7 (Suppl. 1): 151-154.
125. Takahashi K, , Nakanishi S, , Imamura S. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, , and inhibition by NPY through G protein-coupled receptors. J Invest Dermatol 1993: 101: 646-651.
126. Hill J M, , Agoston D V, , Gressens P, , McCune S K. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic events. J Comp Neurol 1994: 342: 186-205.
127. Chijiiwa Y, , Murthy K S, , Grider J R, , Makhlouf G M. Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric muscle cells. Regul Pept 1993: 47: 223-232.
128. Fabre C, , el Battari A, , Bellan C et al. Characterization of the oligosaccharide moiety of VIP receptor from the human pancreatic cell line BxPC-3. Peptides 1993: 14: 1331-1338.
129. Calvo J R, , Pozo D, , Guerrero J M. Functional and molecular characterization of VIP receptors and signal transduction in human and rodent immune systems. Adv Neuroimmunol 1996: 6: 397.
130. Pozo D, , Montilla M L, , Guerrero J M, , Calvo J R. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages. Eur J Pharmacol 1997: 321: 379-386.
131. Lutz E M, , Mendelson S, , West K, , Mitchell R, , Harmar A J. Molecular characterisation of novel receptors for PACAP and VIP. Biochem Soc Trans 1995: 23: 83S.
132. Adamou J E, , Aiyar N, , Van Horn S, , Elshourbagy N A. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem Biophys Res Commun 1995: 209: 385-392.
133. Mackay M, , Fantes J, , Scherer S et al. Chromosomal localization in mouse and human of the vasoactive intestinal peptide receptor type 2 gene: a possible contributor to the holoprosencephaly 3 phenotype. Genomics 1996: 37: 345-353.
134. Sreedharan S P, , Huang J X, , Cheung M C, , Goetzl E J. Structure, , expression, , and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc NatI Acad Sci USA 1995: 92: 2939-2943.
135. Anand P, , Bloom S R, , McGregor G P. Topical capsaicin pretreatment inhibits axon reflex vasodilatation caused by somatostatin and vasoactive intestinal polypeptide in human skin. Br J Pharmacol 1983: 78: 665-669.
136. Warren J B, , Wilson A J, , Loi R K, , Coughlan M L. Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J 1993: 7: 1394-1400.
137. Eedy D J, , Shaw C, , Johnston C F, , Buchanan K D. The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin Exp Dermatol 1994: 19: 463-472.
138. Eedy D J, , Shaw C, , Armstrong E P, , Johnston C F, , Buchanan K D. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, , specific binding sites and presence in secretions. Br J Dermatol 1990: 123: 65-76.
139. Sato K, , Sato F. Effect of VIP on sweat secretion and cAMP accumulation in isolated simian eccrine glands. Am J Physiol 1987: 253: R935-941.
140. Haegerstrand A, , Jonzon B, , Dalsgaard C J, , Nilsson J. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA 1989: 86: 5993-5996.
141. Wollina U, , Huschenbeck J, , Knoll B, , Sternberg B, , Hipler U C. Vasoactive intestinal peptide supports induced migration of human keratinocytes and their colonization of an artificial polyurethane matrix. Regul Pept 1997: 70: 29-36.
142. Pincelli C, , Fantini F, , Romualdi P et al. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 1992: 98: 421-427.
143. Rayan G M, , Johnson C, , Pitha J, , Cahill S, , Said S. Vasoactive intestinal peptide and nerve growth factor effects on nerve regeneration. J Okla State Med Assoc 1995: 88: 337-341.
144. Hartmeyer M, , Scholzen T, , Becher E, , Bhardwaj R S, , Schwarz T, , Luger T A. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J Immunol 1997: 159: 1930-1937.
145. Scholzen T, , Kalden D-H, , Luger T A, , Armstrong C A. Ansel J C. cc-melanocyte-stimulating hormone (cc-MSH) modulates TNF-a- or IL-lβ-induced production of interleukin 8 and Grocc by human dermal microvascular endothelial cells. Arch Dermatol Res 1998: 290: 104 [Abstract].
146. Böhm M, , Schulte U, , Goez R et al. Human dermal fibroblasts express melanocortin-1 receptors and respond to amelanocyte stimulating hormone with increased secretion of IL-8. Arch Dermatol Res 1988: 290: 104 [Abstract].
147. Lipton J M, , Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today 1997: 18: 140-145.
148. Bhardwaj R S, , Schwarz A, , Becher E et al. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996: 156: 2517-2521.
149. Bhardwaj R, , Becher E, , Mahnke K et al. Evidence for thé differential expression of the functional alpha-melanocytestimulating hormone receptor MC-1 on human monocytes. J Immunol 1997: 158: 3378-3384.
150. Brzoska T, , Kalden D-H, , Scholzen T et al. alpha-MSH
151. inhibits the IL-1 mediated chemokine induction via NF-KB inactivation. Arch Dermatol Res 1998: 290: 75 [Abstract].
152. Kalden D-H, , Brzoska T, , Scholzen T et al. The neuropeptide a-MSH antagonizes the hPS-induced activation of transcription factor NF-icB in human endothelial cells. Arch Dermatol Res 1998: 290: 38 [Abstract].
153. Farooqui J Z, , Medrano E E, , Abdel-Malek Z, , Nordlund J. The expression of proopiomelanocortin and various POMC-derived peptides in mouse and human skin. Ann N Y Acad Sci 1993: 680: 508-510.
154. Cone R D, , Lu D, , Koppula S et al. The melanocortin receptors: agonists, , antagonists, , and the hormonal control of pigmentation. Recent Prog Horm Res 1996: 51: 287-317.
155. Wintzen M, , Gilchrest B A. Proopiomelanocortin, , its derived peptides, , and the skin. J Invest Dermatol 1996: 106: 3-10.
156. Nadel J A. Peptidase modulation of neurogenic inflammation. In: Geppetti P, , Holzer P, , eds. Neurogenic inflammation. Boca Raton, , New York, , London, , Tokyo: CRC Press Inc. 1996: 115-127.
157. Caldwell P R, , Seegal B C, , Hsu K C, , Das M, , Soffer R L. Angiotensin-converting enzyme: vascular endothelial localization. Science 1976: 191: 1050-1051.
158. Johnson A R, , Ashton J, , Schulz W W, , Erdos E G. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Resp Dis 1985: 132: 564-568.
159. Smallridge R C, , Gamblin G T, , Eil C. Angiotensin-converting enzyme: characteristics in human skin fibroblasts. Metabolism: 1986: 35: 899-904.
160. Muns G, , Vishwanatha J K, , Rubinstein I. Effects of smokeless tobacco on chemically transformed hamster oral keratinocytes: role of angiotensin I-converting enzyme. Carcinogenesis 1994: 15: 1325-1327.
161. Olerud J E, , Usui M L, , Seckin D, , Chiu D S, , Ansei J C, , Bunnett N W. Neutral endopeptidase (NEP) expression by human keratinocytes. J Invest Dermatol 1997: 108: 607 [Abstract].
162. Roques B P, , Noble F, , Crine P, , Fournie-Zaluski M C. Inhibitors of neprilysin: design, , pharmacological and clinical applications. Methods Enzymol 1995: 248: 263-283.
163. Pham I, , Gonzalez W, , Doucet J, , Fournie-Zaluski M C, , Roques B P, , Michel J B. Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin. Eur J Pharmacol 1996: 296: 267-276.
164. Andersson R G, , Karlberg B E, , Lindgren B R, , Persson K, , Rosenqvist U. Enalaprilat, , but not cilazaprilat, , increases inflammatory skin reactions in guinea-pigs. Drugs 1991: 41 (Suppl. 1): 48-53.
165. Holder I A, , Neely A N. Hageman factor-dependent kinin activation in burns and its theoretical relationship to postburn immunosuppression syndrome and infection. J Burn Care Rehabil 1990: 11: 496-503.
166. Neely A N, , Imwalle A R, , Holder I A. Recombinant neutral endopeptidase decreases oedema in the skin of burned guinea-pigs. Burns 1996: 22: 520-523.
167. Rubinstein I, , Iwamoto I, , Ueki I F, , Borson D B, , Nadel J A. Recombinant neutral endopeptidase attenuates substance P-induced plasma extravasation in the guinea pig skin. Int Arch Allergy Appl Immunol 1990: 91: 232-238.
168. Lu B, , Gerard N P, , Kolakowski L F, , Jr. et al. Neutral endopeptidase modulation of septic shock. J Exp Med 1995: 181: 2271-2275.
169. Lu B, , Figini M, , Emanueli C et al. The control of microvascular permeability and blood pressure by neutral endopeptidase. Nat Med 1997: 3: 904-907.
170. Okamoto A, , Lovett M, , Payan D G, , Bunnett N W. Interactions between neutral endopeptidase (EC 3.4.24.11) and
171. the substance P (NK1) receptor expressed in mammalian cells. Biochem J 1994: 299: 683-693.
172. Borson D B, , Brokaw J J, , Sekizawa K, , McDonald D M, , Nadel J A. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 1989: 66: 2653-2658.
173. Hwang L, , Leichter R, , Okamoto A, , Payan D G, , Collins S M, , Bunnett N W. Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine. Am J Physiol 1993: 264: G735-743.
174. Werb Z, , Clark E J. Phorbol diesters regulate expression of the membrane neutral metalloendopeptidase (EC 3.4.24.11) in rabbit synovial fibroblasts and mammary epithelial cells. J Biol Chem 1989: 264: 9111-9113.
175. Kondepudi A, , Johnson A. Cytokines increase neutral endopeptidase activity in lung fibroblasts. Am J Respir Cell Mol Biol 1993: 8: 4319.
176. Graf K, , Kunkel K, , Zhang M et al. Activation of adenylate cyclase and phosphodiesterase inhibition enhance neutral endopeptidase activity in human endothelial cells. Peptides 1995: 16: 1273-1278.
177. Borson D B, , Gruenert D C. Glucocorticoids induce neutral endopeptidase in transformed human trachéal epithelial cells. Am J Physiol 1991: 260: L83-89.
178. Ihara H, , Nakanishi S. Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids. J Biol Chem 1990: 265: 22441-22445.
179. Girolomoni G, , Tigelaar R E. Capsaicin-sensitive primary sensory neurons are potent modulators of murine delayedtype hypersensitivity reactions. J Immunol 1990: 145: 1105-1112.
180. Ek L, , Theodorsson E. Tachykinins and calcitonin gene-related peptide in oxazolone-induced allergic contact dermatitis in mice. J Invest Dermatol 1990: 94: 761-763.
181. Pastore S, , Cavani A, , Girolomoni G. Epidermal cytokine and neuronal peptide modulation of contact hypersensitivity reactions. Immunopharmacology 1996: 31: 117-130.
182. Zachariae H, , Henningsen S J. Histamine and plasma kinins in delayed allergic skin reactions. Allergie und Asthma 1970: 16: 9-14.
183. Payan D G, , Levine J D, , Goetzl E J. Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol 1984: 132: 1601-1604.
184. Wallengren J, , Moller H. Some neuropeptides as modulators of experimental contact allergy. Contact Dermatitis 1988: 19: 351-354.
185. Wallengren J. Substance P antagonist inhibits immediate and delayed-type cutaneous hypersensitivity reactions. Br J Dermatol 1991: 124: 324-328.
186. Gutwald J, , Goebeler M, , Sorg C. Neuropeplides enhance irritant and allergic contact dermatitis. J Invest Dermatol 1991: 96: 695-698.
187. Goebeler M, , Henseleit U, , Roth J, , Sorg C. Substance P and calcitonin gene-related peptide modulate leukocyte infiltration to mouse skin during allergic contact dermatitis. Arch Dermatol Res 1994: 286: 341-346.
188. Clementi G, , Amico-Roxas M, , Caruso A et al. Effects of CGRP in different models of mouse ear inflammation. Life Sci 1994: 54: PLI 19-124.
189. Asahina A, , Hosoi J, , Beissert S, , Stratigos A, , Granstein R D. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 1995: 154: 3056-3061.
190. Yoshikawa T, , Streilein J W. Tumor necrosis factor-alpha and ultraviolet B light have similar effects on contact hypersensitivity in mice. Reg Immunol 1990: 3: 139-144.
191. Fox F E, , Kubin M, , Cassin M. et al. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood niononuclear cells: effects on B7, , interleukin 10, , and interleukin 12. J Invest Dermatol 1997: 108:43-48. ... . .
192. Torii H, , Hosoi J, , Asahina A, , Granstein R D. Calcitonin gene-related peptide arid Langerhans cell function. J Invest Dermatol Symp Proc 1997: 2: 82-86.
193. Bondesson L, , Nordlind K, , Mutt V, , Liden S. Vasoactive intestinal polypeptide inhibits the established allergic contact dermatitis in humans. Ann N Y Acad Sci 1996: 805: 702-707.
194. Bondesson L, , Nordlind K, , Mutt V, , Liden S. Inhibitory effect of vasoactive intestinal polypeptide and ketanserin on established allergic contact dermatitis in man. Acta Derm Venereol 1996: 76: 102-106.
195. Girolomoni G, , Tigelaar R E. Peptidergic neurons and vasoactive intestinal peptide modulate experimental delayed-type hypersensitivity reactions. Ann N Y Acad Sci 1992: 650: 9-12.
196. Grabbe S, , Bhardwaj R S, , Mahnke K, , Simon M M, , Schwarz T, , Luger T A. alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 1996: 156: 473-478.
197. Kondo S, , McKenzie R C, , Sauder D N. Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol 1994: 103: 811-814.
198. Enk A H, , Saloga J, , Becker D, , Mohamadzadeh M, , Knop J. Induction of hapten-specific tolerance by interleukin 10 i/i vivo. J Exp Med 1994: 179: 1397.